What is uniQure's other commercial liabilities?

uniQure (QURE) reported other commercial liabilities of $43.2M in Q1 2026.

How has uniQure's other commercial liabilities changed year-over-year?

uniQure's other commercial liabilities increased by 58.0% year-over-year, from $27.34M to $43.2M.

What is the long-term trend for uniQure's other commercial liabilities?

Over 5 years (2020 to 2025), uniQure's other commercial liabilities has grown at a 18.0% compound annual growth rate (CAGR), from $18.04M to $41.29M.

uniQure QURE Other Commercial Liabilities

Other Commercial Liabilities at other companies

Ultragenyx PharmaceuticalRARE

——

Denali Therapeutics Inc.DNLI

——

CRISPR TherapeuticsCRSP

——

ALN

Alnylam PharmaceuticalsALNY

——

AmgenAMGN

——

Intellia TherapeuticsNTLA

——

Other financials

Income statement

See full

Revenue$3.6M+127%

Gross profit$3.3M+144%

Operating income-$45.7M-16.2%

Net income-$53.5M-22.7%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$140.0M-35.6%

Total debt$63.3M-4.3%

Total equity$149.3M+343%

Total assets$778.7M+28.6%

Cash flow

See full

Operating cash flow-$38.2M+13.3%

CapEx$140.0K+11.1%

Free cash flow-$38.4M+13.2%

Valuation

See full

Market cap$3.09B+78.4%

Enterprise value$3.02B+124%

P/S170.9×+85.1×

Profitability

See full

Gross margin90.6%-2.9pp

Operating margin-1,059.7%+380pp

Net margin-1,154.4%+89.3pp

FCF margin-953.7%+169pp

Returns & leverage

See full

Return on equity-228.2%-11.6pp

Debt / equity0.4×-1.5×

Current ratio10.4×-1.6×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is uniQure's other commercial liabilities?: uniQure (QURE) reported other commercial liabilities of $43.2M in Q1 2026.
How has uniQure's other commercial liabilities changed year-over-year?: uniQure's other commercial liabilities increased by 58.0% year-over-year, from $27.34M to $43.2M.
What is the long-term trend for uniQure's other commercial liabilities?: Over 5 years (2020 to 2025), uniQure's other commercial liabilities has grown at a 18.0% compound annual growth rate (CAGR), from $18.04M to $41.29M.